Correction of the Hyper-IgM Syndrome after Liver and Bone Marrow Transplantation
Nedim Hadi, M.D., Antonio Pagliuca, M.D., Mohamed Rela, M.D., Bernard Portmann, M.D., Alison Jones, Ph.D., Paul Veys, M.D., Nigel D. Heaton, M.D., Ghulam J. Mufti, M.D., and Giorgina Mieli-Vergani, Ph.D.
Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.
The hyper-IgM syndrome, a rare form of combined primary immunodeficiency,is characterized by neutropenia and defective B-cell isotypeswitching, which results in elevated or normal levels of serumIgM and low levels of serum IgG, IgA, and IgE.1 Clinically,patients with the syndrome have serious pyogenic infectionscaused by encapsulated bacteria, suggestive of the presenceof humoral immunodeficiency. They are also susceptible to infectionswith intracellular pathogens such as Pneumocystis carinii, Cryptosporidiumparvum, and leishmania, because of a possible defect in cellularimmunity.2,3
The inheritance is usually X-linked, but autosomal recessiveand autosomal dominant forms have also been documented.4 The. . . [Full Text of this Article]
Case Report
Methods
Results
Liver Transplantation
Bone Marrow Transplantation
Discussion
Source Information
From the Departments of Child Health (N.H., G.M.-V.), Haematological Medicine (A.P., G.J.M.), and Transplant Surgery (M.R., N.D.H.) and the Institute of Liver Studies (B.P.), King's College Hospital; and the Host Defense Unit, Hospital for Sick Children (A.J., P.V.) both in London.
Address reprint requests to Dr. Hadi at the Department of Child Health, King's College Hospital, Denmark Hill, London SE5 9RJ, United Kingdom, or at nedim.hadzic@kcl.ac.uk.
References
This article has been cited by other articles:
Yong, P F K, Post, F A, Gilmour, K C, Grosse-Kreul, D, King, A, Easterbrook, P, Ibrahim, M A A
(2008). Cerebral toxoplasmosis in a middle-aged man as first presentation of primary immunodeficiency due to a hypomorphic mutation in the CD40 ligand gene. J. Clin. Pathol.
61: 1220-1222
[Abstract][Full Text]
Lim, M. S., Elenitoba-Johnson, K. S.J.
(2004). The Molecular Pathology of Primary Immunodeficiencies. J. Mol. Diagn.
6: 59-83
[Full Text]
Jacobsohn, D. A., Emerick, K. M., Scholl, P., Melin-Aldana, H., O'Gorman, M., Duerst, R., Kletzel, M.
(2004). Nonmyeloablative Hematopoietic Stem Cell Transplant for X-Linked Hyper-Immunoglobulin M Syndrome With Cholangiopathy. Pediatrics
113: e122-127
[Abstract][Full Text]
Gennery, A. R., Khawaja, K., Veys, P., Bredius, R. G. M., Notarangelo, L. D., Mazzolari, E., Fischer, A., Landais, P., Cavazzana-Calvo, M., Friedrich, W., Fasth, A., Wulffraat, N. M., Matthes-Martin, S., Bensoussan, D., Bordigoni, P., Lange, A., Pagliuca, A., Andolina, M., Cant, A. J., Davies, E. G.
(2004). Treatment of CD40 ligand deficiency by hematopoietic stem cell transplantation: a survey of the European experience, 1993-2002. Blood
103: 1152-1157
[Abstract][Full Text]
Cooper, M. D., Lanier, L. L., Conley, M. E., Puck, J. M.
(2003). Immunodeficiency Disorders. ASH Education Book
2003: 314-330
[Abstract][Full Text]
Arkwright, P. D., Abinun, M., Cant, A. J.
(2002). Autoimmunity in human primary immunodeficiency diseases. Blood
99: 2694-2702
[Abstract][Full Text]
Khawaja, K, Gennery, A R, Flood, T J, Abinun, M, Cant, A J
(2001). Bone marrow transplantation for CD40 ligand deficiency: a single centre experience. Arch. Dis. Child.
84: 508-511
[Abstract][Full Text]
Matthes-Martin, S., Peters, C., Konigsrainer, A., Fritsch, G., Lion, T., Heitger, A., Kapelari, K., Kronberger, M., Offner, F., Wrba, F., Margreiter, R., Gadner, H.
(2000). Successful stem cell transplantation following orthotopic liver transplantation from the same haploidentical family donor in a girl with hemophagocytic lymphohistiocytosis. Blood
96: 3997-3999
[Abstract][Full Text]
Saleem, M A, Arkwright, P D, Davies, E G, Cant, A J, Veys, P A
(2000). Clinical course of patients with major histocompatibility complex class II deficiency. Arch. Dis. Child.
83: 356-359
[Abstract][Full Text]